A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya®

Clinical trial NCT01705236 · COMPLETED

Trial details

NCT number: NCT01705236
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis RRMS

Start date: 2012-08-20
Primary completion: 2019-02-18
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.